Health Care & Life Sciences » Medical Equipment & Supplies | Green Cross Medical Science Corp.

Green Cross Medical Science Corp. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
2,178
3,717
603
2,560
2,344
Depreciation, Depletion & Amortization
814
1,356
2,102
2,648
2,742
Other Funds
484
1,330
64
1,971
3,178
Funds from Operations
3,475
6,403
2,769
2,060
3,576
Changes in Working Capital
373
8,621
8,214
8,187
468
Net Operating Cash Flow
3,848
2,218
5,445
10,247
3,108
Capital Expenditures
3,639
3,396
4,060
2,100
1,134
Sale of Fixed Assets & Businesses
1
4
59
36
38
Purchase/Sale of Investments
220
136
-
822
594
Net Investing Cash Flow
5,296
3,528
7,080
2,886
502
Cash Dividends Paid - Total
-
-
478
-
-
Issuance/Reduction of Debt, Net
1,886
7,631
13,760
6,886
247
Net Financing Cash Flow
1,886
4,261
13,282
6,886
785
Net Change in Cash
418
1,485
759
495
1,752
Free Cash Flow
1,024
4,778
8,715
8,361
2,003
Net Assets from Acquisitions
1,878
-
2,914
-
-
Change in Capital Stock
-
11,892
-
-
538
Exchange Rate Effect
20
-
2
20
69
Other Uses
-
-
164
-
-

About Green Cross Medical Science

View Profile
Address
107 Ihyeon-ro 30beon-gil
Yongin-si GY 16924
Korea, Republic Of
Employees -
Website http://www.greencrossms.com
Updated 09/14/2018
Green Cross Medical Science Corp. engages in the manufacture and sale of in vitro diagnostic reagent products, medical equipment, and other medical supplies. It operates through following business divisions: Diagnostic Medicine, Blood Bag, Dialysate, and Diabetes. The company offers diagnostic reagents including diagnostic kit (ELISA), pregnancy and ovulation tests, rapid tests, magnetic immuno-chromatographic test (MICT), bleeding disorder tests, molecular subtyping tests, biochemical reagents, real-time polymerase chain reaction (PCR), and allergy tests.